Profit

Bet on Cipla, Ranbaxy, says Deven Choksey

PUBLISHED ON: May 7, 2012 | Duration: 6 min, 57 sec

  
loading..
Deven Choksey, MD of KR Choksey Securities feels that pharma companies can be good, defensive bets currently. He likes Cipla in the pharma pack. "Ranbaxy is attractive at current valuations," he said in a chat with NDTV Profit's Prashant Nair.
ALSO WATCH
तीन महीने बाद जहांगीरपुरी में खुले बाजार

................................ Advertisement ................................

................................ Advertisement ................................

Listen to the latest songs, only on JioSaavn.com